10 August 2022
: Case report 
A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome
Challenging differential diagnosis, Unexpected drug reaction, Rare disease
Alexis Hilts1EF*, Ariyon Schreiber
1EF, Aditi Singh1E
DOI: 10.12659/AJCR.936896
Am J Case Rep 2022; 23:e936896
Table 1. Laboratory findings consistent with GBS.
| CSF studies | On admission |
|---|---|
| Appearance | Colorless |
| Protein | 417 mg/dl |
| Glucose | 67 mg/dl |
| Gram stain | NGTD |
| White cell count | 1 cells/mm |
| RBC | 20 cells/mm |
| CSF – cerebrospinal fluids. | |